The United Arab Emirates has registered the Russian Sputnik V vaccine against the coronavirus, according to the Russian Direct Investment Fund (RDIF).
“The Sputnik V vaccine is registered in the UAE as part of an accelerated procedure based on the results of phase III clinical trials in Russia involving more than 33,000 people,” the RDIF said in a statement on Thursday.
In the Emirates, the third phase of clinical trials is currently ongoing under the supervision of the UAE Ministry of Health and Prevention and the Abu Dhabi Department of Health with the participation of 1,000 volunteers.
RDIF CEO Kirill Dmitriev said that “the UAE is one of Russia’s key partners in the Middle East.” “The decision to include Sputnik V in the UAE’s national vaccine portfolio is an important step in protecting the population,” he said.
The vaccine was previously registered under a similar emergency use authorization in Argentina, Hungary, Bolivia, Serbia, Algeria, Palestine, Venezuela, Paraguay and Turkmenistan. Sputnik V is also registered in Russia and Belarus.
The vaccine will be supplied to the UAE by RDIF’s international partners in India, China, South Korea and other countries.